Market Tracker

12/11 5:15pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.64
Delayed Data
As of 4:00pm ET
 -0.53 / -8.59%
Today’s Change
4.60
Today|||52-Week Range
11.72
-34.72%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close6.17
Today’s open6.18
Day’s range5.63 - 6.18
Volume1,043,543
Average volume (3 months)1,018,348
Market cap$433.6M
Dividend yield--
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-704.00%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+700.24%
P/E ratioNM
Price/Sales8.73
Price/Book4.13

Competitors

 Today’s
change
Today’s
% change
ABEOAbeona Therapeutics ...-0.65-4.01%
ASMBAssembly Biosciences...-0.29-0.65%
KPTIKaryopharm Therapeut...-0.60-5.40%
CMTAClementia Pharmaceut...-0.76-4.53%
Data as of 4:00pm ET, 12/11/2017

Financials

Next reporting dateMarch 15, 2018
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$69.4M
Annual profit (last year)$10.8M
Net profit margin15.56%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Robert Baker
CFO, Principal Accounting Officer &
Senior VP
Patrick Fabbio
Corporate headquarters
Tarrytown, New York

Forecasts